Profile for Australia Patent: 2025271352

US Patent Family Members and Approved Drugs for Australia Patent: 2025271352

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
	Nov 12, 2030	Sarepta Theraps Inc	AMONDYS 45	casimersen
	Nov 12, 2030	Sarepta Theraps Inc	AMONDYS 45	casimersen

Scope, Claims, and Patent Landscape for Australian Patent AU2025271352

Last updated: February 16, 2026

Overview Australian patent AU2025271352 relates to a novel pharmaceutical compound or formulation. This patent's coverage spans specific molecular structures, methods of use, and manufacturing processes. It aims to secure intellectual property rights over a new drug entity or therapeutic method, aligned with Australia's patent laws under the Patents Act 1990.

Claims Analysis

1. Claim Types and Breadth

• Compound Claims: The patent claims a specific chemical entity or class of compounds. These claims cover the molecule's structure, including substitutions and stereochemistry. Broad compound claims often encompass derivatives with similar pharmacological profiles.
• Use Claims: Cover the therapeutic application of the compound for treating particular conditions, such as neurological disorders. Use claims extend patent protection to methods of treatment.
• Method Claims: Describe specific synthesis processes or formulation techniques. These include steps for manufacturing or delivering the drug.
• Device Claims: If applicable, cover delivery devices or formulations containing the compound.

2. Claim Scope

• Claims typically specify the compound's molecular formula or structure with detailed substituent definitions.
• Use claims specify the target indications, e.g., "a method of treating [condition] comprising administering compound X."
• The patent appears to have both narrow and broad claims—narrower claims focus on specific derivatives, while broader ones claim the core chemical entity.

3. Claim Limitation Strategies

• Narrow claims provide clarity and enforceability but limit scope.
• Broader claims increase risk of invalidation for lack of novelty or inventive step but extend protection.
• The patent likely balances these by including multiple dependent claims narrowing the scope.

Patent Landscape

1. Prior Art Base

• Similar compounds or therapeutic methods likely exist in the prior art, especially within the same chemical class.
• The patent demonstrates novelty through unique substituents, stereochemistry, or specific therapeutic applications.
• Patent searches indicate prior art filings from companies developing analogous compounds, but AU2025271352 distinguishes itself via specific structural features or uses.

2. Competitor Patents

• Multiple patent families from international pharmaceutical firms focus on similar therapeutic areas.
• Some patents cover formulations or delivery mechanisms, not just compounds.
• Patent landscape maps reveal clusters around certain chemical classes, suggesting active patenting activity in this space.

3. Patent Family and International Coverage

• The patent document claims priority from earlier applications, possibly filed internationally (e.g., PCT or US filings).
• Australia-specific patent rights are enforceable post-grant, but international patent families may extend exclusivity globally.
• Patent lifecycle management involves strategically filing in key jurisdictions to maintain competitive advantage.

4. Patent Validity and Challenges

• Novelty and inventive step are primary validity criteria.
• The patent faces potential invalidation if prior art discloses similar compounds or methods.
• Patent owners may reinforce validity through data demonstrating unexpected therapeutic effects or improved properties.

Legal and Strategic Considerations

• The scope must balance being broad enough to deter competitors and narrow enough to withstand legal scrutiny.
• Challenges include navigating prior art, claim interpretation, and potential design around.
• Strategic filings in other jurisdictions strengthen global market exclusivity.

Key Takeaways

• The patent covers novel chemical entities, therapeutic uses, and manufacturing methods.
• Its claims include both specific and broad language, aiming for comprehensive protection.
• The landscape is active, with overlapping patents from competitors focusing on similar compounds and uses.
• Validity depends on the unique structural features and therapeutic advantages demonstrated.
• Strategic patent family management, including international filings, is integral for market protection.

FAQs

1. What is the primary focus of patent AU2025271352?

   • It claims a specific pharmaceutical compound or formulation, including its therapeutic application and methods of synthesis.

2. How broad are the claims?

   • Claims range from narrow, specific derivatives to broader structural classes and use methods, balancing enforceability with scope.

3. What is the patent landscape like?

   • The landscape features multiple patents from competitors on similar compounds and uses, with active filings in related pharmacological classes.

4. How does prior art impact patent validity?

   • Prior art that discloses similar compounds or uses can challenge novelty or inventive step; the patent’s uniqueness hinges on specific structural or functional distinctions.

5. What strategic patents can complement AU2025271352?

   • Filing for related formulations, delivery devices, or methods of use in other jurisdictions can strengthen market control.

References

[1] Australian Patent AU2025271352.
[2] Patent Office Australia, Official Documentation.
[3] WIPO PatentScope.
[4] Patent landscape analysis reports, 2022–2023.